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Background: Knowledge of the responsiveness of cells within
the periodontal region to specific bioactive agents is important
for improving regenerative therapies. The aim of this study was
to determine the effect of specific growth factors, insulin-like
growth factor-I (IGF-I), platelet-derived growth factor-BB (PDGF-
BB), and transforming growth factor-β (TGF-β) on cemento-
blasts in vitro and ex vivo.
Methods: Osteocalcin (OC) promoter driven SV40 transgenic
mice were used to obtain immortalized cementoblasts. Growth
factor effects on DNA synthesis were assayed by [3H]-thymidine
incorporation. Northern analysis was used to determine the
effects of growth factors on gene expression profile. Effects of
growth factors on cementoblast induced biomineralization were
determined in vitro (von Kossa stain) and ex vivo (re-implan-
tation of cells in immunodeficient (SCID) mice).
Results: All growth factors stimulated DNA synthesis com-
pared to control. Twenty-four hour exposure of cells to PDGF-
BB or TGF-β resulted in a decrease in bone sialoprotein (BSP)
and osteocalcin (OCN) mRNAs while PDGF-BB also increased
osteopontin (OPN) mRNA. Cells exposed to IGF-I for 24 hours
exhibited decreased transcripts for OCN and OPN with an upreg-
ulation of BSP mRNA noted at 72 hours. In vitro mineralization
was inhibited by continuous application of PDGF-BB or TGF-β,
while cells exposed to these factors prior to implantation into
SCID mice still promoted biomineralization.
Conclusions: These data indicate IGF-I, PDGF-BB, and TGF-
β influence mitogenesis, phenotypic gene expression profile,
and biomineralization potential of cementoblasts suggesting that
such factors alone or in combination with other agents may pro-
vide trigger factors required for regenerating periodontal tissues.
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Restoring lost periodontium, the ulti-mate goal of regenerative peri-odontal therapy, requires functional
and anatomical reconstruction of a mul-
titude of tissues including cementum,
periodontal ligament, bone, and gingiva.
Toward this goal research efforts have
focused on determining the cells, factors,
and mechanisms fostering periodontal
wound healing. Increased understanding
of mediators required for promoting peri-
odontal regeneration has led to improved
techniques directed toward enhancing
healing and regeneration of periodontal
tissues lost as a consequence of dis-
ease.1-3 A specific concern for the clin-
ician has been the limited predictability
of forming regenerative cementum,
which is considered a prerequisite for
complete restoration of periodontal tis-
sues.4 Therefore, understanding the mo-
lecular mechanisms and cell dynamics
of cementogenesis during development
and healing of periodontal tissues is
important to improving regenerative
techniques. The molecular and cellular
events involved in controlling cemento-
genesis have not been studied widely due
to limited tools, including lack of cemen-
toblast cultures.5,6 Toward this aim our
laboratory determined the timed and
spatial expression of molecules during
tooth root development in situ.7-9 Root
lining cells, cementoblasts, were found
to express markers associated with cells
involved in mineral formation such as
bone sialoprotein (BSP) and osteocalcin
(OCN). This selective expression profile
enabled us to establish cementoblast cell
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lines independent from surrounding periodontal liga-
ment (PDL) cells. The availability of cementoblast cell
lines allows us to seek answers to many questions that
previously have been difficult to address. The accu-
mulating evidence indicating that growth factors, under
appropriate conditions, have positive effects on wound
healing10,11 prompted us to evaluate their effects on
cementoblasts in vitro.
Growth factors possess diverse activities including
the ability to stimulate cell migration, proliferation, dif-
ferentiation, and matrix synthesis, all activities known
to be important in tissue repair.12 More specifically,
increasing evidence has accumulated from both in
vitro13-16 and in vivo17-21 studies to support a role for
growth factors for use in regenerative periodontal ther-
apy. Factors considered to have a positive impact on
periodontal regeneration include platelet-derived growth
factor (PDGF); insulin-like growth factor (IGF); fibro-
blast growth factor (FGF); transforming growth fac-
tor-β 1, -2, and -3, (TGF-β); and bone morphogenetic
proteins (BMPs) belonging to TGF-β superfamily.3,22
However, specific cells, as well as the response of cells
to these factors, have not been completely defined.4,10
Most notably, limited data exist regarding the effects
of growth factors on cementoblasts. Knowledge as to
the responsiveness of cementoblasts to growth factors
may provide critical information important for design-
ing regenerative therapies.
The aim of this investigation was to determine
whether the growth factors IGF-I, PDGF-BB, and
TGF-β, known to have an effect on PDL cells and on
osteoblasts, alter cementoblast behavior. Cell activi-
ties examined included mitogenic activity in vitro, cell
differentiation in vitro, and induction of mineralization
in vitro and ex vivo.
MATERIALS AND METHODS
Isolation and Culture of Mouse Cementoblast Cell
Line
An immortalized cementoblast cell line was used for
these studies. As described previously, these cells were
obtained using osteocalcin (OC) promoter-driven SV-
40 T antigen transgenic mice (OC-TAg) provided by
Dr. Jolene Windle.23,24 The 2.6-kb fragment of rat OC
promoter driving the expression of SV-40 TAg ensures
that cells expressing OC (cementoblasts) are prefer-
entially immortalized. Therefore when cells from the
surrounding tooth are cultured, only cementoblasts,
not PDL cells, survive.
Briefly, first mandibular molars of mice day 41 (vagi-
nal plug day = 0) were used, based on previous data
in situ8 and in vitro,7 which indicated that at this time
cells along the root surface, cementoblasts, express
high levels of mineralized tissue-associated markers
BSP and OCN mRNA. Mandibles were dissected and
hemisected and molars were removed by carefully cut-
ting into the PDL using a dissecting microscope thereby
ensuring that osteoblasts from surrounding alveolar
bone were excluded. Collagenase/trypsin digestion was
used to isolate cementoblasts from the surface of first
mandibular molars. Cultured cells were termed “OC-
CM” to indicate cementoblasts (CM) derived from OC-
TAg mice. Limiting dilutions were used to obtain clonal
cell lines. For this purpose, one cell/well was plated in
each of 96-well tissue culture plates and subclones
were generated and expanded. OC-CM subclone 30
(OCCM-30), which expresses BSP and OCN mRNAs,
indicative of cementoblasts in situ, was used for this
study. OC-CM-30 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM)§ supplemented with
10% fetal bovine serum (FBS), 100 units/ml penicillin
and 100 µl streptomycin, and incubated in an humid-
ified atmosphere of 5% CO2 at 37°C. Cells were used
between passages 9 to 12.
Growth Factors
The growth factors evaluated in this study included
recombinant human insulin-like growth factor-I (rhIGF-
I); recombinant human platelet derived growth factor-
BB (rhPDGF-BB); and recombinant human trans-
forming growth factor-β1 (rhTGF-β).
DNA Synthesis Assay
To measure the mitogenic effects of growth factors on
cementoblasts, [3H]-thymidine incorporation assay was
used as previously described.15 Initially a dose-
response experiment was carried out with 3 different
concentrations for each growth factor to determine cell
responsiveness (data not shown). Concentrations used
were 50 to 200 ng/ml for IGF-I, 15 to 60 ng/ml for
PDGF-BB, and 2 to 8 ng/ml for TGF-β. Concentra-
tions were selected based on previous studies from
our laboratory25 and others where PDL cells and
osteoblasts were exposed to growth factors.15,26,27
Optimal concentrations for growth factors, as deter-
mined by ability to enhance proliferation, were 100
ng/ml for IGF-I, 30 ng/ml for PDGF-BB, and 4 ng/ml
for TGF-β. Cells were seeded in 24-multiwell plates at
a density of 1 × 105 cells/well in triplicate and incu-
bated for 24 hours in DMEM containing 10% FBS and
antibiotics. Media were removed, wells were rinsed
twice with phosphate buffered saline (PBS), and then
serum-free DMEM was added for 24 hours. Next, cells
were exposed to growth factors in serum-free DMEM
for 20 hours and pulsed with 3 µCi/ml methyl-[3H]-
thymidine¶ during the last 4 hours of incubation.
Serum-free media were used as a negative, while media
with 10% FBS, where FBS is known to contain numer-
ous growth factors, were used as a positive control. Fol-
lowing labeling, cells were rinsed with PBS and incu-
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bated with 5% (w/v) trichloroacetic acid (TCA) for one
hour. The precipitate was solubilized with 250 µl 1%
sodium dodecyl sulfate (SDS) at 55°C for 2 hours and
counted in a liquid scintillation counter.# The DNA syn-
thesis assay was repeated 3 times with similar results
observed. Results are expressed as CPM ± S.D.
Northern Analysis
OC-CM-30 cementoblasts were seeded at an initial
density of 5 × 104 cells/cm2 in 100 mm cell culture
plates using DMEM supplemented with 10% FBS, 100
units/ml penicillin, and 100 µl streptomycin and incu-
bated in an humidified atmosphere of 5% CO2 at 37°C
overnight to allow for cell attachment. On the follow-
ing day media were changed to DMEM containing 2%
FBS with antibiotics, specific growth factors, and min-
eralization components. In order to promote mineral-
ization 50 µg/ml ascorbic acid (AA) and 10 mM β-
glycerophosphate (βGP), previously shown to induce
mineralization of cementoblasts and osteoblasts, were
added to the cells.24,28,29 Cells were exposed to these
conditions for 24 or 72 hours. Total RNA was isolated
using a modified guanidium isothiocyanate, sodium
citrate, sodium acetate, phenol, and chloroform extrac-
tion. After quantifying by spectroscopy,30 RNA (10 µg)
was electrophoresed on a 6% formaldehyde and 1.2%
agarose gel, transferred onto a nylon membrane** and
immobilized using an UV irradiation unit.†† Blots were
hybridized with random primed 32P radiolabeled
probes‡‡ and exposed to Kodak X-OMAT film with
intensifying screens at −70°C for 24 to 72 hours.
Probes
Probes used for Northern analysis included: bone sialo-
protein: mouse-BSP cDNA in PCR II vector containing
a 1 kb PCR product of mouse inserted by TA cloning31
(a gift from Dr. M. Young, NIDCR/NIH); osteocalcin:
mouse-OCN cDNA cloned into pSP65 cloning vec-
tor32 (a gift from Dr. J. Wozney, Genetics Institute);
osteopontin: mouse-OP-3 cDNA in PCR II vector con-
taining 1kb PCR product33 (a gift from Dr. M. Young
NIDCR /NIH); and GAPDH: a 1100 bp cDNA cloned
into pGEM3.34 GAPDH a “house keeping gene” which
is not affected by cell conditions is used to normalize
loading of mRNA.
Mineralization Assay
In vitro: von Kossa. Mineralization assay was per-
formed as previously described.24,28,29 Concentrations
selected were the same as those used for DNA syn-
thesis and gene expression assays. For continuous
application groups, cells were plated in 24-multiwell
culture dishes at an initial density of 5 × 104 in tripli-
cate and were grown for 8 days in the presence of
growth factors, 2% FBS, and AA. For pulse applica-
tion groups, cells were grown in the presence of growth
factors for the first 24 hours, whereas AA and 2% FBS
were present during the entire 8-day experimental
period. Media were replenished every other day. Con-
trol wells received DMEM containing 2% FBS with or
without AA, as a positive and negative control, respec-
tively. Three mM inorganic phosphate (monobasic
NaH2PO4) was added to all wells during the last 48
hours of incubation. At the termination of the experi-
ment the cells were fixed with absolute ethanol and
stained by using von Kossa method to detect mineral
nodule formation in vitro.28,29 Black staining is indica-
tive of mineral nodule formation.
In vivo: SCID mice. The influence of growth fac-
tors on mineral induction by OC-CM 30 cells ex vivo
was determined using SCID mice. Homozygous 7- to
9-week-old male C.B.-17 scid/scid (SCID) mice§§ were
used. The ability of OC-CM 30 cells to promote min-
eralization in this model has been reported previously.35
A mixture of hydroxyapatite/tricalcium phosphate pow-
der (HA/TCP) and bovine Type I collagen,  was used
as a delivery system for the cells. OC-CM 30 cells
were exposed to DMEM containing 2% FBS and either
30 ng/ml PDGF-BB or 4 ng/ml TGF-β and were main-
tained in culture for 24 hours or 72 hours. The implants
were prepared by using 4 mm × 4 mm sponges and
soaking sponges in DMEM for 30 minutes. Sponges
were compressed between 2 pieces of sterile What-
man filter paper to remove air prior to adding cells
and then were inserted into microcentrifuge tubes con-
taining 2 × 106 cells in 30 µl DMEM. After anesthesia
with methoxyflurane¶¶ a mid-longitudinal skin incision
of approximately 1 cm in length was made on the dor-
sal surface. Subcutaneous pouches were created by
blunt dissection in 3 different directions in order to
enable fascia to separate individual implants.36 PDGF-
BB and TGF-β treated and graft-only implants were
engrafted into separate pockets in the same animal
and incisions were closed with surgical staples. For
each treatment, 3 animals were used. After 6 weeks
the mice were sacrificed and samples were retrieved
and fixed in neutral buffered formalin (10% v/v) and
embedded in paraffin. Five micron thick sections were
prepared and stained with hematoxylin and eosin
(H&E). All procedures were performed under Univer-
sity of Michigan Unit for Laboratory Animal Medicine
(ULAM) approved guidelines for the use of animals in
research.
Statistical Analysis
To determine statistical significance one-way analysis
of variance (ANOVA) and Tukey-Kramer multiple com-
parison test were used.
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RESULTS
DNA Synthesis (Fig. 1)
Many growth factors enhance cell proliferation and,
therefore, to determine the mitogenic response of OC-
CM-30 cells to specific growth factors, a [3H]-thymi-
dine incorporation assay was used. When compared
with control (serum-free DMEM), IGF-I, PDGF-BB, and
TGF-β increased DNA synthesis in OC-CM 30 cells (P
<0.001). [3H]-thymidine uptake for PDGF-BB treated
cells was similar to 10% FBS (positive control) and
significantly greater than that of TGF-β, IGF-I, and 0%
FBS (negative control). TGF-β and IGF-I had compa-
rable effects on DNA synthesis.
Gene Expression (Fig. 2)
In addition to affecting cell proliferation, many growth
factors also alter gene expression and subsequently
cell differentiation. The effects of the growth factors
above on gene expression for OPN, BSP, and OCN,
genes associated with the cementoblast phenotype,
were determined using Northern analysis. Representa-
tive results from one experiment, where similar results
were noted on 3 separate occasions are shown in Fig-
ure 2. Figures 2A and 2B show the Northern blot data,
while in Figure 2C the differences observed have been
normalized to GAPDH, to compensate for changes in
loading of mRNA. Cells treated with PDGF-BB and TGF-
β for 24 hours exhibited a significant down-regulation
of BSP and OCN mRNAs, while the PDGF-BB group
also upregulated OPN mRNA when compared with 2%
FBS plus AA control (2% AA) (Fig. 2A). This effect on
OPN mRNA levels was also noted in cells exposed to
TGF-β, but only after 72 hours exposure (Fig. 2B). By
72 hours, cells exposed to PDGF-BB and TGF-β had
increased mRNAs for both BSP and OCN when com-
pared with mRNAs at 24 hours; however, relative to 2%
AA control at 72 hours transcripts for BSP and OCN still
remained reduced, with a more noticeable reduction
remaining for BSP mRNA (Fig. 2B).
Effects of IGF-I on these genes were different from
those of PDGF-BB and TGF-β. IGF-I inhibited both
OPN and OCN gene expression at 24 hours (Fig. 2A).
At 72 hours OPN mRNA remained downregulated,
whereas OCN mRNA levels were comparable to 2%
AA (Fig. 2B). Most interesting was the effect of IGF-I
on BSP mRNA, where BSP is considered a key pro-
tein in the regulation of mineral formation. At 24 hours
IGF-I had no effect on BSP transcripts beyond that of
2% AA control while at 72 hours IGF-I exposed cells
expressed higher levels of BSP transcripts when com-
pared to 2% AA control, where this effect was seen in
3 separate experiments (Figs. 2A and 2B).
Mineralization
Since changes in gene expression may reflect changes
in other cell activities, the ability of cementoblasts to
promote mineralization in vitro and in vivo, after expo-
sure to growth factors, was determined. Results shown
in Figure 3 represent one experiment where each agent
was examined in triplicate wells. The experiment was
repeated 3 times with similar results.
In vitro (Fig. 3). The ability of growth factors to
alter cementoblast-induced biomineralization was
determined by von Kossa staining. As previously
reported,24 cementoblasts promote mineral nodule for-
mation in the presence of 2% FBS+AA, but not in the
absence of AA (Figs. 3A and B, bottom row). Mineral
nodule formation was inhibited in cells exposed con-
tinuously to PDGF-BB and TGF-β. In contrast, IGF-I did
not affect mineralization either in vitro or in vivo when
compared to 2% FBS positive control (data not shown).
In order to determine whether a short exposure to
PDGF-BB or TGF-β, which would promote proliferation,
would enhance the ability of cells to induce a mineral
matrix, cells were exposed to factors for the first 24
hours of the 8-day experiment. As shown in Figure
3B, under these conditions, cells pulsed with growth
factors were able to promote mineral nodule formation
but mineralization remained less than the 2% FBS pos-
itive control. Furthermore this inhibitory effect was
more apparent with TGF-β exposed cells versus PDGF-
BB exposed cells.
Ex vivo (Fig. 4). To assess the effect of growth fac-
tors on mineral formation induced by OC-CM 30 cells
ex vivo, cell/HA/TCP sponges were implanted in SCID
mice and prepared for histological analysis 6 weeks
post-transplantation. All implants, with or without cells,
were encapsulated at the time of retrieval. HA/TCP
implant material only, used as the carrier, was shown
to be incapable of inducing mineralized matrix at 6
weeks (Fig. 4A). Histological analysis of tissue sam-
ples obtained from SCID mice containing OC-
CM/HA/TCP implants revealed mineral formation at 6
weeks (positive control, Fig. 4D), but not at 1 week
(Fig. 4B) or 3 weeks (Fig. 4C) post-implantation.
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Figure 1.
Effect of growth factors on DNA synthesis measured by [3H]-
thymidine incorporation. Each bar represents the mean ± SD. Results
from a representative experiment of 3 repetitions are shown.
* P <0.001: 10% FBS and PDGF-BB>TGF-ß and IGF-I and 0% FBS;
† P <0.001:TGF-ß & IGF-I > 0% FBS.
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TGF-β, and positive control. Inter-
estingly, although histomorphomet-
ric analysis was not performed, at
the macroscopic level PDGF-BB and
TGF-β treated specimens appeared
to demonstrate enhanced neovas-
cularization at the time of retrieval
when compared to positive control
(data not shown).
DISCUSSION
Substantial evidence exists sug-
gesting that growth factors can pro-
mote periodontal regeneration, al-
though the specific cell interactions
have not been established.2,11,22
Studies here demonstrating that IGF-
I, PDGF-BB, and TGF-β influence
the activities of cementoblasts, in
vitro, further support the use of
these factors in regenerative thera-
pies.
A fundamental process for heal-
ing and development is cell prolif-
eration. PDGF-BB, TGF-β, and IGF-
I all significantly stimulated DNA
synthesis in OC-CM 30 cells. PDGF-
BB was the most potent at the doses
and times studied. This is not sur-
prising since several studies have
shown consistently that PDGF pro-
motes proliferation of mesenchymal
cells, including human PDL cells,13,37
human pulp fibroblasts,37 pre-
osteoblasts and osteoblasts.26,38,39
Furthermore, as also noted for
cementoblasts, Piche and Graves40
reported that PDGF was more mito-
genic than TGF-β, IGF-I, or EGF for
human osteoblastic cells. Similarly,
results for IGF-I are in line with pre-
vious studies, where IGF-I has been
shown to be a mitogen for PDL cells
and osteoblasts.15,41 In contrast to
the consistent proliferative effects
reported for PDGF-BB or IGF-I, existing data indicate that
TGF-β has varied effects, including enhancing or inhibit-
ing proliferation and having anabolic or catabolic activ-
ity.42,43 These differences have been attributed to sev-
eral factors including concentration,44-46 culture
conditions,47,48 maturity of cells,49 differences in anatomic
origin of cells, and animal species.47,48,50
While promotion of cell proliferation is important for
bone wound healing, several additional events must occur
for periodontal repair to proceed. These include cell dif-
ferentiation and biomineralization of appropriate tissues.
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Figure 2.
Gene expression analysis.Total RNA was isolated and subjected to Northern analysis. Genes probed:
OPN, osteopontin; BSP, bone sialoprotein; OCN, osteocalcin; and GAPDH, “housekeeping” gene to
normalize loading of mRNA. Factors: IGF-I, insulin-like growth factor-I; PDGF-BB, platelet derived
growth factor-BB;TGF-ß, transforming growth factor-ß; 2% w/AA: cells incubated with DMEM
containing 2% FBS, ascorbic acid and ß-glycerophosphate (positive control). A. 24-hour exposure to
growth factors; B. 72-hour exposure to growth factors; C. normalization of OPN, BSP, and OCN
mRNA to GAPDH mRNA at 24 and 72 hours post-treatment. Results from a representative
experiment of 3 repetitions are shown.
C
Hence, 6 weeks of healing was determined as optimal
for biomineralization to occur and was used for sub-
sequent studies.
OC-CM 30 cementoblasts, pretreated with either
PDGF-BB or TGF-β for 24 or 72 hours in vitro and
then seeded onto HA/TCP for implantation in vivo,
promoted mineralization (Figs. 4E, F, G, and H). Min-
eral deposition developed from the surface into the
center of the grafts for all specimens that mineralized.
Light microscopic evaluation of tissues indicated sim-
ilar appearance of cells and mineral for PDGF-BB,
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To address these issues with regard to cementoblast
function, Northern analyses and mineralization assays
were used. Previous studies from our laboratory,51 as
well as others,52 have shown that cementoblasts
express mineral-associated proteins including osteo-
pontin, bone sialoprotein, and osteocalcin; however,
factors regulating their expression have not been
explored in depth. BSP and OCN are highly specific to
mineralized tissues.53 Evidence to date suggests that
BSP is a nucleator of hydroxyapatite crystal forma-
tion,54,55 while osteocalcin appears to play a role in
early phases of mineralization and in regulation of crys-
tal growth.55-57 Osteopontin, which has been identi-
fied in several tissues,58 promotes the migration and
attachment of both osteoblasts and osteoclasts and
regulates crystal growth.59,60 Thus, the ability of growth
factors to modulate these genes in cementoblasts is
likely to have significant effects on cell function.
Northern analysis indicated that cells exposed to
PDGF-BB or TGF-β for 24 hours exhibited downregu-
lation of BSP and OCN mRNAs when compared to
untreated cells, which were sustained for 72 hours
(Figs. 2A and B). Concurrently, OPN mRNA was
upregulated at 24 hours in PDGF-BB treated cells, and
at 72 hours in TGF-β treated cells. The ability of fac-
tors to enhance OPN mRNA levels may prove valuable
for use in periodontal regenerative therapies, where
elevation of OPN levels in the extracellular matrix, by
inhibiting crystal growth, may prevent ankylosis.
Effects of PDGF-BB on cementoblast gene expression
are consistent with previous data from our laboratory
with osteoblast cultures,25 as well as that of several
other laboratories,61-63 where it
has been shown that PDGF-BB
promotes cell proliferation, while
decreasing the level of genes and
gene products associated with cell
differentiation. The effect of TGF-
β on cementoblast genes is con-
sistent with some previous stud-
ies as well. Similar to our findings,
rat osteosarcoma cells and non-
transformed osteoblast-like cells
when exposed to TGF-β, exhibit
upregulation of OPN transcripts64-67
and downregulation of OCN.27,68
IGF-I also inhibited OCN mRNA
expression; however, unlike PDGF-
BB and TGF-β, IGF-I inhibited OPN
expression at 24 hours and upreg-
ulated BSP at 72 hours. Increased
BSP gene expression at 72 hours
suggests that IGF-I may have a
specific role in mineral formation,
since BSP is implicated in pro-
moting crystal growth. Interest-
ingly, PDGF and IGF appear to act synergistically to
promote periodontal tissue regeneration.69 Several rea-
sons for this effect have been proposed including the
ability of IGF-I to nullify the collagenolytic effects of
PDGF.15 PDGF also has been reported to activate both
the IGF-I receptor gene promoter and corresponding
IGF-I receptor mRNA in fibroblasts.70 Our studies sug-
gest that these effects may be attributed to enhance-
ment of proliferation by PDGF coupled with promotion
of mineral formation by IGF (i.e., BSP upregulation).
Therefore, factors in combination that can enhance cell
proliferation and also promote mineralization may pro-
vide the balance needed to establish a functional PDL
with intervening bone and cementum formation.
Another requirement of periodontal regeneration is
the promotion of biomineralization, thus these exper-
iments were designed to determine whether growth
factors influence the ability of cementoblasts to pro-
mote mineralization in vitro and ex vivo. Results from
the present study indicate that continuous exposure
of cells to PDGF-BB or TGF-β inhibited mineral nod-
ule formation in vitro (Fig. 3A) and this correlated with
down-regulation of differentiation markers, BSP and
OCN (Fig. 2A). When cells were pulsed with PDGF-
BB or TGF-β for 24 hours and then factors withdrawn,
inhibitory effects on mineralization were reversed to
some degree, being more noticeable for PDGF-BB ver-
sus TGF-β (Fig. 3B). These findings are supported by
other researchers demonstrating that PDGF-BB and
TGF-β inhibit mineralization in vitro.27,63,71 In fact,
Hsieh and Graves63 reported that brief exposure of
osteoblasts to PDGF-BB promoted mineralized nodule
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Figure 3.
Eight-day von Kossa mineralization assay. Cells were exposed to DMEM containing 2% FBS plus 50
µg/ml ascorbic acid and PDGF-BB platelet derived growth factor-BB, 30 ng/ml, or TGF-ß transforming
growth factor-ß, 4 ng/ml, either in a continuous or pulse fashion.As a positive control (2% w/AA;(+)CN),
cells were exposed to DMEM containing 2% FBS plus 50 µg/ml ascorbic acid (AA). Note positive black
staining indicative of mineral nodule formation.As a negative control, AA was omitted (2%(-)CN). Note
absence of stain. A. Continuous treatment: Note that cells exposed to either PDGF or TGF-ß were not
capable of promoting mineral nodule formation. B. Pulse application: Note decreased mineral nodule
formation. Results from a representative experiment of 3 repetitions are shown, where, in each
experiment triplicate wells were used for each growth factor.
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formation, not by promoting cell differ-
entiation, but by enhancing mitogenesis
at early stages of bone formation. In con-
trast to PDGF-BB and TGF-β, IGF-I did
not alter mineral formation when com-
pared to controls. This finding correlates
with the gene profile for cells exposed to
IGF-I; i.e., upregulation of BSP mRNA
levels, a molecule associated with min-
eralization, and down regulation of OCN
and OPN mRNA levels; molecules con-
sidered to regulate the extent of crystal
growth.57,58,72
Next, studies were designed to deter-
mine if mineralization would be altered
under more physiological conditions.
Engraftment of OC-CM 30 cells incorpo-
rated into a HA/TCP vehicle enabled us
to treat these cells with growth factors ex
vivo and determine results in an in vivo
system (Fig. 4). Pretreatment of cultured
cells with PDGF-BB or TGF-β for 24 or
72 hours prior to implantation had no
effect on biomineralization. Thus it
appears that initial inhibitory effects of
these factors on mineralization, in vitro,
can be overcome by the interaction of
implanted cells with the local environ-
ment, in vivo. This finding is supported by
others, demonstrating anabolic effects of
TGF-β on bone metabolism in vivo.73-75
Another interesting finding was the
prominent neovascularization noted in
implants that had been pretreated with
growth factors (Fig. 4). Angiogenesis is
a particularly important requirement for
regeneration. Thus, use of a combination
of factors that promote vascularization,
proliferation, and mineralization within a
suitable vehicle may prove to be valu-
able for improving clinical outcomes of
periodontal regenerative procedures,
especially in challenging areas such as
furcations where minimal vascularization
may hinder the regenerative potential.
Although PDGF-BB and TGF-β do not
have a direct impact on proliferation of
endothelial cells, TGF-β stimulates endo-
thelial cell growth through a cytokine-
related pathway, while PDGF-BB has a
direct effect on vascular smooth muscle
cells.76 Therefore, both factors may work
in concert to promote neovascularization
during periodontal wound healing.
To our knowledge, this study is the first
to investigate the effects of growth factors
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Figure 4.
Biomineralization by cementoblasts ex vivo. Histological sections obtained from implantation of
cells and HA/TCP in immunodeficient SCID mice (original magnification, ×10). A. material
harvested after 6 weeks post-implantation. No mineral formation observed.The scaffold and
granular structure of the material remained. B. OC-CM 30 cells grown in DMEM containing
10% FBS and implanted within HA/TCP, harvested 1 week post-implantation. No evidence of
mineralization was observed. C. OC-CM 30 cells grown in DMEM containing 10% FBS and
seeded in HA/TCP, harvested 3 weeks post-implantation. No evidence of mineralization was
observed. D.OC-CM 30 cells grown in DMEM containing 10% FBS and implanted within
HA/TCP, harvested 6 weeks post-implantation (positive control). Extensive biomineralization was
observed with a woven-type pattern to the mineralized tissue E and F. OC-CM 30 cells treated
with PDGF-BB for 24 or 72 hours, implanted within HA/TCP, harvested 6 weeks post-implan-
tation. Biomineralization was observed throughout the graft and particles, with “woven type”
mineralization. Note abundance of blood vessels throughout the mineralized matrix, especially in
the 72-hour specimen (F). G and H. OC-CM 30 cells treated with TGF-ß for 24 or 72 hours
and implanted within HA/TCP, harvested 6 weeks post-implantation. Biomineralization was ob-
served throughout the graft and particles, with a pattern similar to OC-CM 30 group in 10% FBS.
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on cementoblasts in vitro. Results here demonstrate
that cementoblasts respond to growth factors and thus
may serve as a cell population to target in attempts
to regenerate periodontal tissues. Continued studies
with these in vitro and ex vivo models will enable us
to determine the mechanisms by which growth fac-
tors regulate cementoblasts. Information provided from
such investigations will assist in designing regenera-
tive therapies based on sound biological principles.
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